Dr. Carey Kernodle Anders, MD
- Medicare services, 2024
- 325
- Medicare patients, 2024
- 105
- Part D claims, 2024
- 365
- Publications
- 190
- Clinical trials
- 13
- Practice address
- 2301 Erwin Rd, Durham, NC 27705
- Practice phone
- Call (919) 684-8111
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Anders' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Carey Kernodle Anders is a medical oncologist in Durham, North Carolina
Dr. Anders practices at Duke University Hospital in Durham, North Carolina, part of Duke University.
Dr. Anders' NPI, 1073786893, was assigned on April 13, 2008. Dr. Anders graduated from Brody School Of Medicine At East Carolina University in 2002. Dr. Anders holds North Carolina license 110474.
- NPI
- 1073786893NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3971675885
- NPI enumeration date
- April 13, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (919) 684-8111
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Carey Kernodle Anders practices at Duke University Hospital in Durham, North Carolina
Dr. Anders' primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.
- Duke University Hospital2301 Erwin Rd, Durham, NC 27705 · Durham CountyPhone(919) 684-8111
Source: Dmand AI Affiliation Data
Dr. Carey Kernodle Anders is affiliated with 2 sites of care and 1 medical group
Dr. Anders' primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. Dr. Anders is also affiliated with Duke Regional Hospital. The medical group on file is Duke Health Integrated Practice.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Carey Kernodle Anders' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anders practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Duke University Hospital | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Duke University and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Carey Kernodle Anders is one of 203 medical oncologists in North Carolina
Medical oncology is Dr. Anders' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Anders is board certified in medical oncology by the American Board of Internal Medicine. Dr. Anders is licensed in North Carolina.
Specialties and state licenses
- Medical oncology, North CarolinaPrimary
Clinical focus
Dmand AI lists breast cancer, chronic anemia and lung cancer among the conditions Dr. Anders treats.
Medical oncologists near Dr. Anders
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Carey Kernodle Anders billed Medicare for 325 services in 2024
CMS data shows 325 Medicare services from Dr. Anders across 4 procedure codes in 2024, for 105 Medicare patients. Medicare paid $21,637 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Anders' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2312024: 2205%
- Other services
- 2023: 02024: 105
Dr. Anders compared with the North Carolina median for medical oncologists, 2024
- Dr. Anders
- North Carolina median
- Medicare services
- 325vs 52538% below
- Medicare patients
- 105vs 16637% below
- Part D claims
- 191vs 36748% below
Medians across 199 medical oncologists in North Carolina with Dmand AI profiles that report each measure.
Dr. Anders' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Anders?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Anders and other medical oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Carey Kernodle Anders treated 105 Medicare patients in 2024, average age 67
CMS counts 105 Medicare patients who saw Dr. Anders in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have cancer, and 61% have high blood pressure. Their average risk score is 2.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Anders' median patient age at 65, with 98% women.
Dr. Anders' Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Anders' Medicare patients by sex, 2024
- Women9187%
- Men1413%
Chronic conditions among Dr. Anders' Medicare patients, 2024
- Cancer75%
- High blood pressure61%
- High cholesterol51%
- Arthritis46%
- Anxiety43%
- Mood disorders33%
- Depression28%
- Diabetes27%
Share of Medicare patients with each condition. A patient can have several.
Dr. Anders' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 65
Patient panel by sex, all payers
- Women98%
- Men2%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Carey Kernodle Anders wrote 365 Medicare Part D claims in 2024
In 2024, Dr. Anders wrote 365 Medicare Part D claims for 71 patients. 55% of them were for generic drugs. CMS names the drug for 191 of them, across 8 drugs with 11 or more claims each, at $1,375,556 in total drug cost. In 2023, CMS named 153 claims across 7 drugs.
Dr. Anders' Part D claims by kind of drug, 2024
- Generic199 claims55%
- Brand-name166 claims45%
Dr. Anders' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Anders' Part D claims, 2024
- Opioids5%17 of 365 claims
- Antibiotics3%11 of 365 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1532024: 19125%
Drugs named by CMS: 8 in 2024, 7 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Carey Kernodle Anders takes part in Medicare
Dr. Anders accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Carey Kernodle Anders has 190 publications on record
Dmand AI links 190 papers to Dr. Anders, published from 2008 to 2025. 2017 was the busiest year, with 14. The most frequent topics are Breast Neoplasms, Brain Neoplasms and Receptor, ErbB-2. Dr. Anders has published most often in Breast Cancer Res Treat. Dr. Anders' most frequent co-authors are Sarah Lenoir Sammons, MD, Matthew G. Ewend and Elizabeth C. Dees, MD.
Dr. Anders' papers by year, 2016 to 2025
Topics Dr. Anders writes about most
- Breast Neoplasms
- Brain Neoplasms
- Receptor, ErbB-2
- Antineoplastic Combined Chemotherapy Protocols
- Triple Negative Breast Neoplasms
- Antineoplastic Agents
- Biomarkers, Tumor
- Trastuzumab
Dr. Anders' most frequent co-authors
- Sarah Lenoir Sammons, MD14 shared papers
- Matthew G. Ewend12 shared papers
- Elizabeth C. Dees, MD11 shared papers
Recent publications by Dr. Anders
Acta Neuropathol Commun
Acta Neuropathol Commun
See who Dr. Anders researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Anders works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Carey Kernodle Anders has worked on 13 clinical trials
Dmand AI links Dr. Anders to 13 clinical trials, 5 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Brain Neoplasms and Triple Negative Breast Neoplasms. Dana-Farber Cancer Institute sponsors the most, 2. Open Payments lists research payments to Dr. Anders that name 2 trials.
Clinical trials with Dr. Anders by phase
- 1Early phase 1: 1 trial
- 1Phase 1: 1 trial
- 1Phase 1/2: 1 trial
- 5Phase 2: 5 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. Anders' trials
- Breast Neoplasms
- Brain Neoplasms
- Triple Negative Breast Neoplasms
- Breast Diseases
- Central Nervous System Neoplasms
Investigators on the most trials with Dr. Anders
- Lowell L. Hart, MD3 shared trials
- Ciara Catherine O'Sullivan, MD3 shared trials
- Vandana Gupta Abramson, MD2 shared trials
Recent clinical trials with Dr. Anders
AURORA US: Prospective Biospecimen Repository in Metastatic Breast Cancer (opens in a new tab)
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy (opens in a new tab)
Phase II Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer (opens in a new tab)
Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Carey Kernodle Anders received $129,687 in industry payments from 2016 to 2025
CMS Open Payments shows 110 general payments to Dr. Anders from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 89% of the total. Genentech, Inc. paid the most, $26,232. It also lists 8 research payments totaling $10,960 from 2016 to 2025, naming 2 clinical trials.
General payments to Dr. Anders by program year, 2016 to 2025
General payments to Dr. Anders by kind, 2016 to 2025
- Consulting fees$115,33189%
- Speaker and faculty fees$6,4005%
- Travel and lodging$3,9523%
- Honoraria$2,0002%
- Other$2,0042%
Companies that paid Dr. Anders the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Carey Kernodle Anders graduated from Brody School Of Medicine At East Carolina University
Dr. Anders graduated from Brody School Of Medicine At East Carolina University in 2002.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Carey Kernodle Anders accepts plans from 18 insurance carriers
Dr. Anders is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Blue Cross Blue Shield of Michigan
- United Healthcare
- Blue Cross and Blue Shield of North Carolina
- Cigna
- HCSC
- Aspirus Health Plan
- +10 more carriersWith a free account
Plan types Dr. Anders accepts, by number of carriers
- PPO11
- Medicare10
- HMO9
- POS5
- EPO4
- Medicaid2
Source: Dmand AI Insurance Network Data
Sources for Dr. Carey Kernodle Anders's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Carey Kernodle Anders
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Carey Kernodle Anders' NPI number?
Dr. Carey Kernodle Anders' NPI number is 1073786893. It was assigned on April 13, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Carey Kernodle Anders?
Dr. Carey Kernodle Anders is a medical oncologist in Durham, North Carolina. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Carey Kernodle Anders practice?
Dr. Anders practices at 2301 Erwin Rd, Durham, NC 27705. Dr. Anders' primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University.
What is Dr. Carey Kernodle Anders' office phone number?
The practice phone on file for Dr. Anders is (919) 684-8111.
What is Dr. Carey Kernodle Anders' medical license number?
Dr. Anders holds North Carolina license 110474.
Which hospitals is Dr. Carey Kernodle Anders affiliated with?
Dr. Anders practices at Duke University Hospital in Durham, North Carolina. Dr. Anders is also affiliated with Duke Regional Hospital.
What medical group is Dr. Carey Kernodle Anders part of?
Dr. Anders is linked to Duke Health Integrated Practice.
Does Dr. Carey Kernodle Anders accept Medicare?
Yes. CMS data shows Dr. Anders billed Medicare for 325 services in 2024, and Dr. Anders accepts Medicare assignment.
How many Medicare patients does Dr. Carey Kernodle Anders see?
CMS counts 105 Medicare patients who saw Dr. Anders in 2024, with an average age of 67.
Is Dr. Carey Kernodle Anders board certified?
Yes. Dr. Anders is board certified in medical oncology by the American Board of Internal Medicine.
Show 8 more questionsShow fewer questions
What services does Dr. Carey Kernodle Anders bill to Medicare?
In 2024, Dr. Anders' most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and hospital inpatient care (99233).
Where did Dr. Carey Kernodle Anders go to medical school?
Dr. Anders graduated from Brody School Of Medicine At East Carolina University in 2002.
What drugs does Dr. Carey Kernodle Anders prescribe most?
In 2024 Medicare Part D data, Dr. Anders' most prescribed drugs by claims were Ibrance, Letrozole and Verzenio.
Has Dr. Carey Kernodle Anders received payments from drug or device companies?
CMS Open Payments shows $129,687 in general payments to Dr. Anders from 17 companies from 2016 to 2025. The largest total came from Genentech, Inc.
How long has Dr. Carey Kernodle Anders been practicing?
Dr. Anders graduated from medical school in 2002, 24 years ago.
Does Dr. Carey Kernodle Anders do research?
Dmand AI links 190 publications to Dr. Anders, published from 2008 to 2025. Dr. Anders has worked on 13 clinical trials.
Who does Dr. Carey Kernodle Anders publish with?
Dr. Anders' most frequent co-authors are Sarah Lenoir Sammons, MD (14 shared papers), Matthew G. Ewend (12 shared papers) and Elizabeth C. Dees, MD (11 shared papers).
What insurance does Dr. Carey Kernodle Anders accept?
Dr. Anders is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card